1. You are here:
  2. BioIndustry Association
  3. News & Insights
  4. Resources
  5. Advice on employee inventor compensation in the UK following Shanks v Unilever
Best Practice
3 August 2020

Advice on employee inventor compensation in the UK following Shanks v Unilever

This guide provides legal commentary on employee compensation schemes following the UK Supreme Court's ruling in Shanks vs Unilver. It has been prepared by Will James of Osborne Clarke with support from other members of the BIA IP Advisory Committee. This guide is not comprehensive and is not intended to constitute legal advice or opinion
BIA legal guide to employee inventor compensation.pdf 137 KB
Download

Related topics

IP and tech transfer
Return to listing

You may also be interested in

Website banners (1).png
14 July 2025

Influencing and shaping our sector: April - June 2025

This quarter has seen a cascade of government policy announcements, including the Spending Review and Industrial Strategy. Our team have been rigorously scrutinising and gearing up for the launch of the Life Sciences Sector Plan and the NHS 10-Year Health Plan, two transformative frameworks that could redefine the future of our sector.

Sector insights/Reports
poolbeg pharma.png
20 March 2025

Poolbeg Pharma granted patent in Korea

Poolbeg Pharma announces that the Korean Intellectual Property Office has notified the Company of its official decision to grant Poolbeg's Republic of Korea Immunomodulator II patent application providing protection to POLB 001 for the treatment of severe influenza to December 2038.  

Member news